Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) announced the publication of phase 1 clinical data for TNX-1500, an investigational monoclonal antibody ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA